Recent Finacing
Recent Raise
DioGenix develops and commercializes molecular diagnostic assays, notably MSPrecise—a sequencing-based test for early multiple sclerosis—running prospective clinical trials, operating a central CLIA-focused laboratory, and licensing core technology.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor